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Conclusion: Preliminary analysis of our data shows encouraging
results with YCF stent in all comer high risk ACS population.
Coronary angioplasty in unprotected
left main disease with indigenous
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polymer Yukon choice flex stent
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Twenty patients with unprotected left main disease undergoing
coronary angioplasty between January 2013 and August 2015 have
been studied. Therewere 15males (75%) and 5 females (25%),mean
age 63  11 (35–75 years). Risk factors were Type II Diabetes melli-
tus 7 (35%), Hypertension 8 (40%), Smoking 5 (25%), and Dyslipi-
demia 8 (40%). Clinical presentation was ACS with STEMI 3 (15%),
unstable angina 7 (35%), NSTEMI 8 (40%), and stable angina 2 (10%).
Mean LVEF of the group was 35  5%. Three patients with STEMI
presented in cardiogenic shock.
Right femoral artery was accessed in all patients. Weight adjusted
heparin, aspirin and clopidogrel or prasugrel were used as antic-
oagulants and antiplatelets, respectively. IABP was inserted in the
3 (15%) patients with cardiogenic shock due to acute MI. GP IIb/IIIa
receptor blockers were used in all patients. Distribution of disease
in left main: ostial lesion 3 (15%), diffuse shaft disease 2 (10%),
distal bifurcation 12 (60%), trifurcation 3 (15%). Additional triple
vessel disease was seen in 10 (50%).
Technique: Left main to LAD cross over stenting without ﬁnal
kissing – 8 (40%), two stents strategy: TAP 6 (30%), Cullotte 1
(5%), and DK Crush 1 (5%). In one patient, single stent strategy
with simultaneous kissing balloon angioplasty in Cx was done.
Proximal optimizationwas done in all patients. Ostial stentingwas
done in 3 (15%) patients. Procedural success was achieved in all
patients. All patients received DES. 15 patients (75%) received
indigenous Yukon choice ﬂex (Biodegradable polymer) stent, 3
(15%) received Medtronic Endeavor stent and 2 (10%) patients
received Xience stent (Abott). Mean stent diameter in left main
was 4.0  0.53 mm. Mean number of stents per patient was 1.5. In-
hospital mortality occurred in 3 (15%) patients who were in cardio-
genic shock. There was no other MACE or bleeding during hospi-
talization. Patients were followed clinically or telephonically for a
mean duration of 15  6mo (range 4–20mo). Therewere no further
signiﬁcant events during follow-up.
Conclusion: In appropriately selected patients, PCI of unprotected
leftmain gives gratifying results. The performance of Yukon choice
ﬂex (indigenous) stent has been satisfactory. Mortality remains
high in AMI with cardiogenic shock.
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Background: Contrast induced nephropathy (CIN) is a known
complication following coronary angiography and angioplasty.
Rising creatinine levels after coronary procedures is strongly asso-
ciated with poor clinical outcomes. However in clinical practice
there are situations where coronary procedures are necessary for
patients with pre-existing renal dysfunction. There are some clin-
ical suggestion that trimetazidine (TMZ), an anti-ischemic drug,
may prevent CIN.
Methods: To evaluate the efﬁcacy of trimetazidine in the preven-
tion of CIN in patients with pre-existing renal dysfunction under-
going coronary angiography/angioplasty. It was a prospective
single blind randomized trial where 2 groups of patients of class
III angina with serum creatinine values exceeding 1.5 mg/dl were
selected. One group (group A) was administered intravenous (IV)
saline (0.9%) infusion at a rate of 1 ml/kg of body weight for 24 h
starting 12 h before the procedure while the other group (group B)
received 35 mg twice daily of trimetazidine controlled release (CR)
tablet by mouth for 72 h starting 48 h before the procedure in
addition to IV saline infusion like the ﬁrst group. Baseline serum
creatinine was done 24 h before the procedure for enrolment.
Subsequent creatinine values were obtained 1 h before, and 1, 2,
and 7 days after the procedure.
Results: Over a period of 12months fromApril 1, 2014 till March 31,
2015, 140 patients were included in this study. There were 98 male
patients. Mean age was 67  14 years. Forty eight percent had
diabetes, while 34% were hypertensive and 28% were smokers.
Mean serum creatinine was 1.82  0.44 mg/dl. There were 70
patients in group A, who received only saline infusion and remain-
ing 70 were in group B who had both IV saline and oral trimeta-
zidine CR. Age, sex, risk factors, and clinical symptoms were
properly matched in either group. In all nonionic contrast (Iodix-
anol) was used. One day after angiography/angioplasty there was
no signiﬁcant change of serum creatinine in either group. However
on day 2 post-procedure serum creatinine dropped by mean 8.2%
in group A and 9.5% in group B. The difference was not statistically
signiﬁcant. After 7 days of the procedure mean drop of creatinine
was 8.8% in group A and 12.6% in group B. Reduction of serum
creatinine after 7 days of angiography/angioplasty by TMZ therapy
was statistically signiﬁcant.
Conclusions: The addition of trimetazidine to normal saline sig-
niﬁcantly decreased the incidence of CIN in patients undergoing
coronary angiography/angioplasty. In conclusion, trimetazidine
could be considered as a potential tool for prevention of CIN in
patients with renal dysfunction.
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Background: Although conventional 60 mg prasugrel allows for
rapid and potent platelet inhibition within 30 min after loading
dose, the efﬁcacy and safety of lower doses of prasugrel in Indian
patients has not yet been investigated.
Objective: The study sought to compare the efﬁcacy of a lower
loading dose of prasugrel with conventional loading dose of pra-
sugrel in Indian patients.
Material andmethods: 332 Indian patients undergoing elective PCI
were enrolled in the study. Participants were randomly adminis-
tered loading doses of prasugrel 60 mg (group A, n = 166) or 30 mg
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(group B, n = 166) prior to percutaneous coronary intervention (PCI)
in 1:1 manner. Platelet reactivity was assessed at baseline and at
30 min. Primary endpoint was composite of MACE including in
hospital death, major bleeding and stent thrombosis while sec-
ondary endpoint was in hospital minor bleeding.
Results: Platelet reactivity at baseline and at 30 min did not differ
signiﬁcantly between the two groups ( p = 0.549). The two groups
also did not differ signiﬁcantly in MACE (group A = 2.41%, group
B = 1.81%, OR = 1.34, 95% CI = 0.30–6.09, p = 0.70). Signiﬁcant less
minor bleeding was observed in group B (group A = 10.24%, group
B = 4.22%, OR = 2.59, 95% CI = 1.05–6.43, p = 0.04).
Conclusion: 30 mg prasugrel loading is as effective as 60 mg pra-
sugrel with signiﬁcant less minor bleeding in Indian patients.
Emergency endovascular management
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aneurysm
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Abdominal aortic aneurysms are relatively common, potentially
life threatening conditions that are often asymptomatic and inci-
dentally detected on routine screening for other problems.
Vague abdominal pain and backache are often the presenting
complaints of this disease and are also the commonest complaints
that a doctor comes across in the outpatient as well as the emer-
gency room. Hence it is easy to misdiagnose this condition.
This report will illustrate one such case involving a 57-year-old
male who presented to the gastroenterologist with vague abdom-
inal pain and backache. On further evaluation, an abdominal
aneurysm was incidentally detected on ultrasound. The patient
course and complications that developed along with key points to
be learnt from this case so as to identify this disease at an early
stage and prevent its complications will be highlighted.
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Background: In recent years, vascular closure devices have gained
popularity and are being used for rapid hemostasis and early
ambulation as an alternative to manual compression.
Transradial interventions has been associated with a reduced risk
of vascular complications compared with femoral artery access,
especially access site related bleeding complication leading to
reduction in morbidity in PCI. The transradial access has several
advantages over transfemoral approach. The radial artery is easily
compressible, thus bleeding is controllable and hemorrhagic com-
plications are signiﬁcantly reduced. Moreover, no major nerves or
veins are located near the artery, minimizing the risk of injury of
these structures. Finally, post procedural bed rest is not required,
permitting immediate ambulation, more comfort, and early dis-
charge. This last advantage has shown to improve quality of life for
patients and to reduce the costs of hospitalization. Despite this
large amount of beneﬁts, the transradial approach is more
demanding than transfemoral access and requires a longer learn-
ing curve for the operator. Furthermore, it does not give the
possibility to use other devices such as a temporary pacemaker
or intra-aortic balloon pump and to perform coronary interven-
tions requiring 8-F catheters.
Multiple studies have identiﬁed the incidence of major bleeding as
a strong independent predictor of increased risks of early and late
death or major adverse cardiovascular events (MACE) in patients
presenting with acute coronary syndromes (ACSs) and undergoing
invasive procedures. The access site bleeding represented 50–80%
of all major bleeding, and thus, it is possible that TRA through its
association with lower bleeding risk could favorably inﬂuence the
risk of death andMACE after PCI. Clinicians who performed PCIs in
the early years of the procedure achieved hemostasis after femoral
sheath removal via manual and/or mechanical compression
approaches. These hemostasis strategies required that patients
remain immobilized for extended periods of time (up to 8 h after a
procedure). This approach created substantial discomfort and
extended hospital stays. Alternative methods of achieving hemos-
tasis were introduced into cardiac catheterization laboratories
approximately 20 years ago, loosely termed as vascular closure
devices (VCDs); these alternatives may potentially allow earlier
sheath removal and ambulation with a similar or decreased com-
plication rate compared with manual compression. VCD allow
improved patient satisfaction and comfort related to the avoidance
of prolonged sheath insertion and manual compression. VCD use
allows immediate removal of the femoral sheath regardless of
anticoagulation status. These devices have the potential to reduce
the time to hemostasis, facilitate patient mobilization, decrease
hospital length of stay, and improve patient satisfaction. There-
fore, introducing VCD to close the arterial access site after hemo-
dynamic interventions was designed to reach the same goals as
the introduction of TRA into clinical practice: early mobilization of
the patient, decreased incidence of bleeding complications, and
enhanced patient and staff comfort. Using VCD to close the punc-
ture site after interventions performed via the traditional femoral
artery (FA) approach may offer the same advantages as the TRA,
while achieving a shorter time to reperfusion in patients with
acute coronary syndrome.
Three types of VCDs are commonly used. First are collagen plug
VCDs, second type are suture-based VCDs, and last one are nitinol
clip-based VCDs used for femoral artery hemostasis after PCI. The
suture based Perclose device is used to close the femoral artery
access sites percutaneously following coronary intervention in
fully anticoagulated patients. The Perclose ProGlide Suture-
Mediated Closure (SMC) System is designed to deliver a single
monoﬁlament polypropylene suture to close femoral artery punc-
ture sites following diagnostic or interventional catheterization
procedures. This Perclose ProGlide device is composed of a plun-
ger, handle, guide, and sheath. The Perclose ProGlide tracks over a
standard 0.038’’ (or smaller) guide wire. A hemostasis valve
restricts the blood ﬂow through the sheath with or without the
guidewire in place. The guide houses the needles, and the foot, and
precisely controls the placement of these needles around the
puncture site. The handle is used to stabilize the device during
use. The plunger advances the needles and is used to retrieve the
suture. A marker lumen is contained within the guide, with the
intraluminal port of the lumen positioned at the distal end of the
guide. Proximally, the marker lumen exits from the body of the
device. The marker lumen allows a pathway for back-bleeding
from the femoral artery to ensure proper device positioning.
Methods: In this study after the completion of PCI, the local access
site was closed by the suture based Perclose Proglide VCD of Abbott
Company in patients with transfemoral PCI. The radial compres-
sion band was used for patients who underwent transradial PCI.
The studywas done to see the safety and efﬁcacy of vascular device
closure following transfemoral PCI. The patients were observed for
local site complications like oozing of blood, hematoma, infection,
pseudoaneurysm, A-V ﬁstulae, and death in both femoral
VCD group and radial group. The mean time to ambulation and
discharge were calculated in both group and the results were
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